TMC Life Sciences Berhad (KLSE:TMCLIFE)

Malaysia flag Malaysia · Delayed Price · Currency is MYR
0.530
-0.010 (-1.85%)
At close: Mar 3, 2026
17.78%
Market Cap 870.94M
Revenue (ttm) 387.22M
Net Income (ttm) 12.59M
Shares Out 1.74B
EPS (ttm) 0.01
PE Ratio 69.19
Forward PE n/a
Dividend 0.00 (0.35%)
Ex-Dividend Date Dec 8, 2025
Volume 396,600
Average Volume 580,090
Open 0.540
Previous Close 0.540
Day's Range 0.510 - 0.545
52-Week Range 0.365 - 0.575
Beta 0.25
RSI 57.65
Earnings Date May 22, 2026

About TMC Life Sciences Berhad

TMC Life Sciences Berhad, an investment holding company, provides healthcare services in Malaysia. The company operates Thomson Hospital Kota Damansara hospital located in prime alcove of Kota Damansara. It is involved in providing multi-disciplinary tertiary care, traditional and complementary, obstetrics and gynaecology, fertility services; operating fertility centres and women clinics; property investment; providing pharmacy services and products; management support services; development, marketing, and management of healthcare programmes; a... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1994
Country Malaysia
Stock Exchange Bursa Malaysia
Ticker Symbol TMCLIFE
Full Company Profile

Financial Performance

In fiscal year 2025, TMC Life Sciences Berhad's revenue was 345.63 million, a decrease of -0.23% compared to the previous year's 346.42 million. Earnings were 3.61 million, a decrease of -91.13%.

Financial Statements

News

There is no news available yet.